The Repo homeodomain transcription factor suppresses hematopoiesis in Drosophila and preserves the glial fate by Trébuchet, Guillaume et al.
Development/Plasticity/Repair
The Repo Homeodomain Transcription Factor Suppresses
Hematopoiesis in Drosophila and Preserves the Glial Fate
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Despite their different origins, Drosophila glia and hemocytes are related cell populations that provide an immune function. Drosophila
hemocytes patrol the body cavity and act as macrophages outside the nervous system, whereas glia originate from the neuroepithelium
and provide the scavenger population of the nervous system. Drosophila glia are hence the functional orthologs of vertebrate microglia,
even though the latter are cells of immune origin that subsequently move into the brain during development. Interestingly, the Drosophila
immune cells within (glia) and outside (hemocytes) the nervous system require the same transcription factor glial cells deficient/glial
cells missing (Glide/Gcm) for their development. This raises the issue of how do glia specifically differentiate in the nervous system, and
hemocytes in the procephalic mesoderm. The Repo homeodomain transcription factor and panglial direct target of Glide/Gcm is known
to ensure glial terminal differentiation. Here we show that Repo also takes center stage in the process that discriminates between glia and
hemocytes. First, Repo expression is repressed in the hemocyte anlagen by mesoderm-specific factors. Second, Repo ectopic activation in
the procephalic mesoderm is sufficient to repress the expression of hemocyte-specific genes. Third, the lack of Repo triggers the expres-
sion of hemocyte markers in glia. Thus, a complex network of tissue-specific cues biases the potential of Glide/Gcm. These data allow us
to revise the concept of fate determinants and help us to understand the bases of cell specification. Both sexes were analyzed.
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Introduction
In the Drosophila embryo, lateral glial cells (called glia through-
out the text, for the sake of simplicity) constitute the second
major population of the nervous system and are necessary for
neuronal development, function, and survival. Typically, they
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Significance Statement
Distinct cell types often require the same pioneer transcription factor, raising the issue of how one factor triggers different fates.
In Drosophila, glia and hemocytes provide a scavenger activity within and outside the nervous system, respectively. While they
both require the glial cells deficient/glial cells missing (Glide/Gcm) transcription factor, glia originate from the ectoderm, and
hemocytes from the mesoderm. Here we show that tissue-specific factors inhibit the gliogenic potential of Glide/Gcm in the
mesoderm by repressing the expression of the homeodomain protein Repo, a major glial-specific target of Glide/Gcm. Repo
expression in turn inhibits the expression of hemocyte-specific genes in the nervous system. These cell-specific networks secure
the establishment of the glial fate only in the nervous system and allow cell diversification.
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insulate the CNS upon forming the blood– brain barrier (BBB)
and regulate neurotransmitter recycling, axon guidance, or neu-
ral proliferation (Trébuchet and Giangrande, 2012). During de-
velopment and upon injury, Drosophila glia also act as scavenger
cells and help in reshaping the nervous system. Thus, Drosophila
glia behave like microglia (Logan and Freeman, 2007; Kurant,
2011), vertebrate immune cells of mesodermal origin that move
from the yolk sac into the brain during development and provide
the resident macrophages of the CNS (Ginhoux et al., 2010).
Outside the fly nervous system, hemocytes play a key role in
cellular and humoral immunity. They can move rapidly to patrol
the organism and respond to a variety of challenges. The most
represented subtype of hemocytes, called plasmatocytes, phago-
cyte microbes and sculpt tissues by clearing apoptotic cells during
development (Meister and Lagueux, 2003).
In addition to sharing the immune function, glia and hemo-
cytes express the same transcription factor, the atypical zinc fin-
ger protein Glial cells deficient/Glial cells missing [Glide/Gcm
(called “Gcm” throughout the text); Mao et al., 2012; Cattenoz
and Giangrande, 2013] at early stages of their development. Gcm
is necessary and sufficient to induce gliogenesis and is required
for hemocyte differentiation (for review, see Cattenoz and Gian-
grande, 2015). Thus, the same transcription factor works in func-
tionally related cells that originate from the neurogenic ectoderm
(glia) and from the procephalic mesoderm (PM; hemocytes). In
the nervous system, Gcm induces the expression of the reverse
polarity (Repo) homeodomain containing transcription factor in
all the glial cells. Repo is necessary for the execution of the glial
differentiation program (Yuasa et al., 2003), and embryos lacking
Repo do not express late markers (Halter et al., 1995), including
the scavenger receptor Draper (Drpr; Shklyar et al., 2014). As a
consequence, repo mutant glial cells are not functional and have
defective phagocytic activity (Shklyar et al., 2014).
The shared molecular pathway and role of glia and hemocytes
call for a cell-specific mechanism triggering the differentiation of
embryonic glia and blood in the correct tissue. We here show that
mesodermal cues contribute to prevent glial differentiation in the
hemocyte anlagen. The mesodermal transcription factor Twist
(Twi) induces the expression of miR-1, which in turn represses
Repo post-transcriptionally. This inhibits the gliogenic potential
of Gcm in the PM (Xiong et al., 1994; Halter et al., 1995; Yuasa et
al., 2003), showing that the potential of a fate determinant relies
on the cell-specific transcriptional landscape. The negative regu-
lation of Repo in the hemocyte anlagen is crucial as Repo re-
presses the hemocyte fate: when expressed in the hemocyte
anlagen, it inhibits the expression of hemocyte-specific genes,
and the lack of Repo induces the expression of early hemocyte
markers in the nervous system. Thus, Repo constitutes a major
element in the pathway that discriminates between related but
distinct scavenger fates.
Altogether, our work dissects the complex network that allows
a single pioneer factor to affect different cell fates.
Materials and Methods
Fly stocks. Flies were kept at 25°C. w1118 was used as wild-type (WT).
repo-nGFP and repo-nRFP lines were generated to drive nuclear GFP or
RFP expression under the control of the 4.3kb repo promoter, which
recapitulates the full repo expression pattern (Lee and Jones, 2005; La-
neve et al., 2013). gcm34 (Bernardoni et al., 1999) was used as a gcm
hypomorphic allele carrying a lacZ insertion. The Df(2L)132 (Kammerer
and Giangrande, 2001) deletes the entire gcm locus and was used as a null
allele. repo52, repo84 (Xiong et al., 1994; Halter et al., 1995), twi1 (Cas-
tanon et al., 2001; twi-/CyO_act5cGFP), miR-1KO [catalog #58879,
Bloomington Drosophila Stock Center (BDSC); RRID:BDSC_58879],
and elav4 (catalog #541, BDSC; RRID:BDSC_541) are null alleles.
The UAS/Gal4 system was used for cell-specific manipulation of gene
expression. srp(hemo)Gal4 triggers expression in hemocytes (Brückner et
al., 2004), scaGal4 throughout the neurogenic region (Budnik et al.,
1996), twiGal4 (Baylies and Bate, 1996) throughout the mesoderm, and
gcmGal4 (Soustelle and Giangrande, 2007) combined with repoGal80 (a
gift from B. Altenhein, University of Cologne - Zoological Institute)
throughout the hemocyte anlagen. Finally, repoGal4 was used to drive
gene expression in glial cells (Lee and Jones, 2005).
The following transgenes were also used: UAS-CD8GFP (targeting
GFP expression to the membrane), UAS-RFP (BDSC), UAS-GFP
(BDSC); UASrepo (Yuasa et al., 2003); UAS-twi (Baylies and Bate, 1996),
srp(hemo)RFP (Gyoergy et al., 2018); UAS-gcm(F18A) (see Figs. 2G,G,
Fig. 7; weak Gcm overexpression); and UAS-gcm(RS1) (Fig. 1C–E) or
UAS-gcm(M24A) (Fig. 2G–H; and see Fig. 6; medium Gcm overexpres-
sion; Bernardoni et al., 1998). The combination of UAS-gcm(M24A) and
UAS-gcm(F18A) provided a strong Gcm overexpression (Fig. 2G,G).
Immunohistochemistry. Embryo collections were performed on plates
containing agar, apple juice, and yeast. Dechorionated embryos were
fixed in 4% formaldehyde in PBS for 20 min, permeabilized with 0.3%
Triton X-100 in PBS (PTX), blocked by 0.5% Blocking Reagent (Roche)
in PTX for 1 h and labeled overnight at 4°C with the following antibodies:
rabbit (rb) anti-Repo (1 of 10), mouse (m) anti-Repo (1 of 10; anti-Repo;
catalog #8D12, DSHB; RRID:AB_528448), m anti-Singed (Sn; 1 of
50; catalog #sn 7C, DSHB; RRID:AB_528239), and rat anti-Elav (1 of
200; catalog #Rat-Elav-7E8A10 anti-elav, DSHB; RRID:AB_528218);
guinea pig (gp) anti-Repo (1 of 1000) and gp anti-Nazgul (1 of 200; a gift
from B. Altenhein, University of Cologne - Zoological Institute; von
Hilchen et al., 2010); mouse (m) anti-Ush (1 of 1000; Cubadda et al.,
1997); rb anti-Srp (Serpent; 1 of 1000; a gift from R. Reuter, Institute for
Cell biology - University of Tübingen; Sam et al., 1996; Petersen et al.,
1999); m anti-P1 (1 of 10; a gift from E. Kurucz, Institute of Genetics,
Szeged, Hungary; Kurucz et al., 2007a); rb anti-Croquemort (Crq; 1 of
500; a gift from J.L Dimarcq and J. Hoffmann, Institut de Biologie
Moléculaire et Cellulaire, Strasbourg; Franc et al., 1996); m anti-Fas2 (1
of 100; a gift from C.S. Goodman, Howard Hughes Medical Institute,
University of California; Grenningloh et al., 1991); rb anti-HRP (1 of
500) and rb anti--Gal (1 of 500; Cappel); and chicken anti-GFP (1 of
1000; catalog #ab92456, Abcam; RRID:AB_10561923); m anti--Gal (1
of 200; Sigma-Aldrich); rat anti-RFP (1 of 100; catalog #5f8100, Chro-
moTek; RRID:AB_2336064); and rb anti-DCP-1 (death caspase-1; 1 of
50; catalog #9578, Cell Signaling Technology; RRID:AB_2721060).
The secondary antibodies were FITC-, Cy3, or Cy5 conjugated (1 of
400; Jackson ImmunoResearch). Images were taken with the SP2 or the
SP5 confocal microscopes (Leica) and processed using Fiji (Schindelin et
al., 2012).
Srp signal intensity was measured on confocal images acquired with
hybrid detector in photon-counting mode. The mean gray value mea-
surement tool from Fiji (Fiji; RRID:SCR_002285) was used to estimate
the intensity of the signal (in A.U.) from 50 hemocytes in at least three
embryos (Schindelin et al., 2012).
Cotransfection, Western blot, and luciferase assays. Drosophila S2 cells
were grown in Schneider medium (Thermo Fisher Scientific) comple-
mented with 10% heat-inactivated fetal calf serum and 0.5% penicillin/
streptomycin. A total of 6  10 6 cells were cultured in six-well culture
dish 12 h prior to transfection. Five micrograms of total plasmid mix
were transfected using the Effectene Kit (Qiagen) according to manufac-
turer instructions. The psrp(hemo)Gal4 plasmid provided an srp tran-
scriptional reporter (Brückner et al., 2004) upon cotransfection with the
pUAS-GFP plasmid. The pPac5C-repo plasmid was used to induce Repo
expression (Yuasa et al., 2003), and pPac5C-lacZ as a transfection con-
trol. The pPac5C plasmid was used to equilibrate the amount of trans-
fected DNA. Cells were harvested 24 h after transfection in Tris-HCl 25
mM pH 7.9, 400 mM KCl, and 10% glycerol, and total proteins were
extracted by three freezing–thawing steps. Protein expression was de-
tected from protein lysate according to standard Western blot proce-
dures. The following primary antibodies were used: m anti--Gal (1 of
2500; Sigma-Aldrich), rb anti-GFP (1 of 5000; Invitrogen), and m anti-
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Repo [1 of 20; Developmental Studies Hybridoma Bank at the University
of Iowa (DHSB)]. m anti-HRP and rb anti-HRP (1 of 5000; Jackson
ImmunoResearch) were used as secondary antibodies.
For the luciferase assay, Drosophila S2 cells were cultured in a 24-well
plate, in the same conditions as previously described. Plasmid transfec-
tions were performed using Effectene (Qiagen) following manufac-
turer instructions. pMTGal4-GFP, pUAST-Luciferase-Luciferase 3UTR,
pUAST-Luciferase-Repo 3UTR, pUAST-Luciferase-Repo 3UTR miR-1,
and pTK-Renilla were all used at 20 ng/ml; and pTub-miR-1 was used at
50 ng/ml. The cells were cultured 2 d prior to induction with 500 M
copper sulfate. The luciferase assay was performed 18 h after induction,
using the Dual-Glo Luciferase assay kit (Promega) according to manu-
facturer instructions. Three independent transfections were averaged
with SD. Statistical significance was calculated with GraphPad Prism
software (GraphPad Software; RRID:SCR_002798) using a t test.
RNA extraction, reverse transcription, and quantitative PCR. Total RNA
was purified from stage 5–11 embryos using Tri Reagent (MRC). One
microgram of purified RNA was reverse transcribed by SuperScript II
reverse transcriptase (Invitrogen) using oligodT primers (5 M). mRNAs
were analyzed by quantitative PCR (qPCR) using Sybr Green (Roche)
Master Mix, the thermocycler LightCycler480 (Roche) and the following
oligonucleotides: repo: forward, 5 AAGCAGCAGCAAGAAGAAGG 3;
reverse, 5 ATACGGAGCACGTTCAAAGG 3; and actin5C: forward, 5
GCAGCAACTTCTTCGTCACA 3; reverse, 5 CTTAGCTCAGCCT
CGCCACT 3, For each gene, the mRNA levels were automatically cal-
culated (LightCycler480 Software, release 1.5.0) by calibration to gene-
specific standard curves generated on input cDNAs. Collected values,
derived from three amplification reactions, each performed in three in-
dependent experiments, were normalized to actin5C mRNA amounts.
Statistics. All the experiments were performed in at least three biolog-
ical replicates. Statistical relevance was assigned by calculating means and
SEs. Whenever the data showed normal distribution (Figs. 1E, 2G–H, 3F,
4G), they were analyzed by ANOVA; whenever they did not, (see Fig.
10 F, G) they were analyzed by Kruskal–Wallis and Wilcoxon (W) tests
(*p  0.05; **p  0.01; ***p  0.001). The data analysis for this article
were generated using the Real Statistics Resource Pack software [release
5.4; Charles Zaiontz (www.realstatistics.com)].
Results
The mesoderm-specific transcription factor Twist represses
the expression of the Repo panglial protein
The Gcm transcription factor is expressed in the glial as well as
in the hemocyte lineages, where it controls the expression of glial
and hemocyte genes, respectively (Jones et al., 1995; Bernardoni
et al., 1997, 1998; Lebestky et al., 2000; Alfonso and Jones, 2002;
Figure 1. Twi negatively regulates Repo expression in the nervous system. A–D, Confocal projections of stage 14 sca;repo-nGFP (Control; A–A) and scatwi; repo-nGFP (twi GOF; B–B)
embryos immunolabeled for the glial marker Repo (blue) and the glial reporter repo-nGFP (green). Ventral view. Here and in all figures, anterior is to the left. C, D, Confocal projections of embryos
stage 14 twigcm ( gcm GOF; C) and twigcm;twi-/ ( gcm GOF, twist het; D) immunolabeled for Repo (blue). E, Quantification of the number of Repo-positive cells per embryo in twimedium
gcm and twimedium gcm;twi-/; n  10 embryos, the mean 	 SEM is represented on the chart and the p value was calculated by ANOVA. Scale bar, 100 m. ***p  0.001.
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Figure 2. Twi negatively regulates Repo expression in the hemocytes. A–B, Confocal projections of wild-type (A) and twi 
 / 
 (twi LOF; B–B) embryos labeled for the glial marker Repo (blue)
and for the hemocyte marker Srp (red). Lateral view. B and B represent a single section of the inset indicated in B, they show Srp labeling only and colabeling with Repo, respectively. The white
arrowheads indicate cells coexpressing Srp and Repo. Scale bar, 100 m. C–D4, Confocal projections of control (twi-/CyO_act5cGFP;srp(hemo)RFP/; C–C4) and twi LOF (twi 
 / 
; srp(hemo)RFP;
D–D4) embryos, labeled for GFP (green), Repo (blue), and the hemocyte reporter srp(hemo)RFP (red; Gyoergy et al., 2018). C–C4 and D–D4 show single sections (Figure legend continues.)
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Cattenoz et al., 2016; Bazzi et al., 2018). Since glia differentiate
from the ectoderm, and hemocytes from the PM, we hypothe-
sized that tissue-specific factors regulate the expression of the
Gcm targets in a cell-specific manner. Since Twi is an early
mesoderm-specific transcription factor, we asked whether it re-
presses the expression of Repo, the most characterized glial-
specific target of Gcm that is expressed in all glia. The Repo also
represents the only transcription factor that is exclusively ex-
pressed in glia (Campbell et al., 1994; Xiong et al., 1994; Halter et
al., 1995).
To show that Twi inhibits Repo expression in vivo, we ana-
lyzed embryos in which we induced Twist expression ectopically
[gain of function (GOF)], in the neural territory, as well as em-
bryos that lack Twi expression [loss of function (LOF)] or express
low levels of Twi.
The ectopic expression of Twi in the neurogenic region medi-
ated by the scabrousGal4 driver (scatwi; Budnik et al., 1996)
significantly reduces the number of Repo-positive cells in the
ventral nerve cord (VNC) from an average of 923 	 62 cells in
control to 458 	 38 cells in twi GOF embryos (embryos, n  5;
ANOVA, p  0.000114; Table 1, Fig. 1A,B). In addition to the
Repo antibody, we used the repo-nuclearGFP (repo-nGFP) trans-
gene to follow the glial cells produced in scatwi embryos (Fig.
1A,B). The repo-nGFP transgene faithfully recapitulates the ex-
pression profile of the Repo protein (Lee and Jones, 2005; Laneve
et al., 2013), as we observed coexpression of repo-nGFP and Repo
in 95% of the glial cells (n  3 embryos). Using the transgene
allowed us to show that all the cells that succeed in expressing the
repo gene also express the Repo protein and hence maintain the
glial identity. The decrease in the number of Repo-positive cells
suggests that Twi represses Repo expression; however, we could
not exclude that the forced expression of Twi in the neurogenic
region affects the ability of the neuroblasts to produce glia. If that
were the case, the effect of Twi on Repo would only be indirect.
Hence, we complemented the GOF data by analyzing embryos
that lack Twi expression (analyzing twi LOF) partially or com-
pletely. Since the expression of Gcm in the mesoderm triggers
gliogenesis at the expense of muscles (Bernardoni et al., 1998), we
performed the same experiment in embryos that carry half a dose
of Twi, which is a potent muscle determinant (Baylies and Bate,
1996) and found that this significantly enhances the gliogenic
potential of Gcm in the mesoderm. These data were obtained
upon expressing Gcm with the twistGal4 driver (twigcm) in
twi/ heterozygous embryos (Table 1, Fig. 1C–E).
Finally, we analyzed the Repo expression in embryos that
completely lack Twi. Although the absence of Twi induces severe
and early defects (Thisse et al., 1987), it is not absolutely required
for the initial determination of the hemocyte fate (Spahn et al.,
2014). This allowed us to analyze the few twi-null embryos that
reached relatively late stages and revealed the presence of the
Repo protein in cells that express the early hemocyte marker Srp
(no cell in control, and an average of 8.9 	 4.3 cells Srp and Repo
positive per embryo twi LOF; n  5 embryos; W test, p  0.0038;
Fig. 2A,B). In addition to hemocytes, Srp is also expressed in the
fat body. Thus, to confirm that the cells coexpressing Srp and
Repo in twi LOF are hemocytes, we combined the srp(hemo)RFP
construct that induces RFP expression specifically in embryonic
hemocytes (Gyoergy et al., 2018) with the twi mutation (Fig. 2C–
D4). Similar to the twi LOF embryos, the twi LOF;srp(hemo)RFP
embryos display hemocytes expressing Repo, with a 40-fold increase
of double-labeled (Repo/RFP) cells compared with those observed
in the control embryos (0.1 	 0.06% RFP-/Repo-positive cells in
Control embryos twi-/;srp(hemo)RFP compared with 4.0 	 0.9%
RFP-/Repo-positive cells in twi LOF embryos twi
 /
;srp(hemo)
RFP; n  4 embryos; ANOVA, p  0.014).
Altogether, our results strongly suggest that the lack of Twi
allows ectopic Repo expression in the hemocyte anlagen, the PM,
hence biasing the gliogenic potential of Gcm in that territory.
We then asked whether overexpressing Gcm in its own do-
main of expression, the PM, leads to the differentiation of super-
numerary hemocytes or whether it bypasses the molecular brake
imposed by Twi and allows ectopic Repo expression. For this
purpose, we crossed a gcmGal4 driver with a transgenic line ex-
pressing the Gal4 inhibitor Gal80 (Lee and Luo, 1999) in glial
cells, the other main territory of Gcm expression [Table 1, gcm-
Gal4, repoGal80, or gcm(hemo)Gal4; Fig. 2E,E], so as to confine
Gcm overexpression to the hemocytes (Fig. 2F–F 5). gcm
(hemo)gcm embryos display Repo expression in the hemocyte
anlagen, and this is a dosage-dependent phenotype. Several UAS-
gcm transgenes were used alone or in combination to generate a
gradient of Gcm levels, which allowed us to show a positive cor-
relation between the levels of Gcm and those of Repo, the stron-
ger the UAS-gcm transgene, the higher the levels of Repo (Fig.
2G,G). Moreover, and in line with our hypothesis, cooverex-
pressing Gcm and Twi ( gcm(hemo)gcm  twi) abolishes the
induction of Repo expression in the PM (Fig. 2H).
The fact that Gcm overexpression induces Repo expression in
the PM could mean that glial differentiation simply requires
higher Gcm levels than hematopoiesis. If that were the case, hy-
pomorphic gcm mutant embryos should express hemocyte mark-
ers in the nervous system. The gcm34 mutation is an imprecise
excision that still expresses the LacZ gene carried by the P element
located at the gcm locus and results in low Gcm levels (Vincent et
al., 1996). Neither gcm34 homozygous nor gcm34/Df(2L)132 tran-
sheterozygous animals (the Df(2L)132 deficiency completely de-
letes the gene; Kammerer and Giangrande, 2001) show Srp
ectopic expression in the nervous system (Fig. 2I–K). This ex-
cludes mere dosage dependency for the establishment of the glial
versus the blood cell fate and further supports the idea that tissue-
specific factors are responsible for it.
In sum, the Twist mesodermal factor negatively affects the
expression of the panglial transcription factor Repo.
4
(Figure legend continued.) of the insets indicated in C and D, respectively, displaying Srp and
Repo labeling (C, D), Repo only (C, D), Srp only (C, D), and in the orthogonal section
along the z- and y-axes of the dashed lines (C4, D4) represented in C and D. Note that
colocalization between Repo and RFP is observed only in twi LOF (white arrowheads). Scale bar,
50 m. E–F5, Confocal projections of an embryo gcmGal4,repoGal80/;UAS-CD8GFP ( gcm
(hemo)CD8GFP; E, E) labeled for Repo (blue) and GFP (green), and of an embryo
gcmGal4,repoGal80/;UASCD8GFP/srp(hemo)RFP ( gcm(hemo)GFP,srp(hemo)RFP; F–F5)
labeled for GFP (green), RFP (red), and HRP (gray). The region defined by the dashed line
indicates the CNS. F–F5 show the inset indicated in F displaying the labeling for HRP, GFP,
and RFP (F), HRP only (F), RFP only (F4), and GFP only (F5). The white arrowheads indicate
the hemocytes; note that GFP expression is excluded from glia. Scale bar, 100 m. G–H, Rela-
tive quantification of gcm (G) and repo mRNA (G, H) by qPCR from stage 5–11 embryos of the
following genotypes: gcm(hemo) (Control) and gcm(hemo) gcm GOF (weak, medium, and
strong gcm GOF; G, G), gcm(hemo) (Control), gcm(hemo)medium gcm (Med. gcm GOF),
and gcm(hemo)medium gcm  twi (Med. gcm GOF, twi GOF; H). gcm and repo levels are
relative to actin levels, n indicates the number of independent assays (for the statistical tests,
see the section on experimental procedures, means 	 SEM are represented on the charts and
the p values were calculated by ANOVA). I–K, Confocal projections of embryonic ventral cords of
the following genotypes: gcm34/ (I), gcm34/gcm34 (J), and gcm34/Df(2L)132 (K). Labeling:
-Gal (green), Srp (red), and the neuronal marker Elav (gray). The gcm34 line represents a P
element partial excision that retains the LacZ gene, allowing monitoring of gcm expression.
-Gal/Srp double-positive cells (yellow, asterisks) are located outside the ventral cord (dashed
line) and label the circulating hemocytes. Scale bar, 100 m. *p  0.05, **p  0.01.
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Figure 3. miR-1 prevents Repo expression in the hemocyte lineage. A, Schematic representation of the repo locus in the Drosophila genome (dm3). UTRs and coding exons are indicated by plain
blue boxes (thin and thick, respectively), and the intron by a blue line. The two putative miR-1 binding sites in the repo 3 UTR are indicated. B–D, Confocal projections of embryos of the following
genotypes: wild-type and miR-1 LOF (
/
), lateral view, stage 14, labeled for Repo (blue), Srp (red), and Elav (gray; B, C) or HRP (D). Note that B–B, C–C, (Figure legend continues.)
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The microRNA miR-1 inhibits Repo expression
post-transcriptionally
The microRNA miR-1 is a direct target of Twi expressed and
required in the mesoderm (Biemar et al., 2005; Sokol and Am-
bros, 2005). We found that miR-1 has two putative target sites in
the repo 3UTR (miRanda; http://www.microrna.org/microrna/
home.do; Fig. 3A) and therefore explored the possibility that it
acts post-transcriptionally on Repo. First, we found that animals
lacking miR-1 display ectopic Repo expression in the PM, similar
to the twi embryos (Fig. 3B–F). Second, we asked whether miR-1
directly acts on the repo 3UTR by cotransfecting S2 Drosophila
cells with a miR-1 expression vector and a luciferase reporter
carrying either the repo 3UTR or its own 3UTR (Fig. 3G). By
measuring the luciferase activity, we found that miR-1 specifically
acts on the repo 3UTR to repress repo expression (Fig. 3G,H).
Third, this negative control is abolished upon mutating the two
putative miR-1 target sites (Fig. 3H). Thus, miR-1 inhibits Repo
expression post-transcriptionally.
In sum, our data indicate that mesoderm-specific cues pre-
vent Gcm from triggering Repo expression in the PM.
Repo is sufficient to repress the expression of hemocyte
markers in the PM
The tight repression of Repo expression in the hemocyte anlagen
suggests that gliogenesis is alternative to hemocyte differentia-
tion. We therefore analyzed the effects of Repo ectopic expression
in the PM upon using the UAS-repo transgene (Yuasa et al.,
2003). gcm(hemo)repo (or repo GOF) hemocytes are severely
affected: many of them aggregate and show altered morphology
as well as migratory defects (Fig. 4A–D). Moreover, they no
longer express the late hemocyte marker NimC/P1, which is a
scavenger receptor expressed starting from stage 14 (Kurucz et
al., 2007a; Fig. 4E,F), and the expression of the early hemocyte
marker Srp is severely downregulated (Fig. 4A–C). The hemo-
cytes express Srp at low levels (Fig. 4A,C, compare arrow-
heads). To quantify this phenotype, we measured the intensity of
Srp labeling and found a significant difference between control
and repo GOF hemocytes [control, 83.4 	 3.9 A.U. (see Materials
and Methods); repo GOF, 12.4 	 1.5 A.U.; n  50 cells in three
embryos; ANOVA, p  6.10
23]. Of note, Srp is also expressed in
the fat body, and yet such expression remains unchanged in repo
GOF animals (Hoshizaki et al., 1994; Fig. 4A,C), showing that
the hemocyte defects are specific and cell autonomous.
More direct evidence for the specific effects of Repo on the srp
gene was obtained by using a srp(hemo)Gal4 driver (srp(hemo))
specific to hemocytes (Brückner et al., 2004). Cotransfecting
S2 Drosophila cells with a Repo expression vector and the srp
(hemo)GFP plasmids severely reduces the expression of the
GFP, and this is a dosage-dependent effect (Fig. 4G,G). We ex-
tended the in vivo analysis by using the srp(hemo) driver and
found phenotypes similar to those observed in gcm(hemo)repo
embryos. In line with the aggregation phenotype described
above, srp (hemo)repo embryos display reduced levels of the
hemocyte marker Sn (also called Fascin; Fig. 5A–B 5), which is
expressed from stage 10 onward and is involved in hemocyte
migration (Zanet et al., 2009; Gyoergy et al., 2018). Like the
gcm(hemo)repo embryos, the srp(hemo)repo embryos also
show a reduced number of hemocytes: 252.8 	 27.4 hemocytes
were counted in control and 136.8 	 19.8 in repo GOF embryos
[n  7 embryos; ANOVA, p  0.0028; counted on 30 m stacks
of confocal images taken from stage 13 embryos (lateral views);
Fig. 5C–D].
Of note, the presumptive hemocytes that ectopically express
Repo with the gcm(hemo) or with the srp(hemo) driver do not
express late glial markers (as monitored by the Nazgul antibody;
von Hilchen et al., 2010; Ryglewski et al., 2017; Fig. 5E–H). The
above data strongly suggest that the expression of the Repo panglial
factor in the PM is detrimental to hemocyte differentiation, and they
are also in line with the fact that Repo is not sufficient to induce the
glial fate when ectopically expressed (Yuasa et al., 2003). Finally,
there is enhanced hemocyte death in gcm(hemo)repo embryos, as
shown by the apoptosis marker cleaved DCP-1 (Song et al., 1997;
Fig. 4H–I; 9.1 	 1.3% of hemocytes display colabeling with DCP-1
in control vs 16.1 	 2.1% in repo GOF embryos, n  7 embryos;
ANOVA, p  0.0150). This likely reflects the inability of hemocytes
expressing Repo to acquire a stable glial fate.
Given the ability of Gcm overexpression in the PM to induce
Repo ectopic expression, we re-examined that phenotype to un-
derstand the relative roles of the two transcription factors in
blood and glial development. Interestingly, the overexpression of
Gcm in the PM induces the expression of both Repo and Nazgul
in the presumptive hemocytes (von Hilchen et al., 2010; Fig. 6A–
D, 18.5 	 1.9% of Repo-positive hemocytes/embryo, n  9
embryos; W test, p  0.0061; and 53.4 	 6.4% Nazgul-positive
hemocytes/embryo, n  3 embryos; W test, p  0.0318 in
gcm(hemo)gcm, compared with 0% in control). Moreover, the
cells that express Repo also express the hemocyte marker Srp (Fig.
6E–E; Rehorn et al., 1996) at levels that are comparable to those
found in wild-type embryos (the intensity of Srp labeling in he-
mocytes from control  83.4 	 3.9 A.U.; from gcm(hemo)
gcm  73.1 	 6.2 A.U.; n  50 hemocytes in three embryos;
ANOVA, p  0.22). Thus, Gcm overexpression induces the ex-
pression of glial genes without blocking hemocyte differentiation.
Since Srp constitutes an early hemocyte factor (Reuter, 1994; Ber-
nardoni et al., 1997; Lebestky et al., 2000), we asked whether late
hemocyte markers are also detected in those cells or whether
hematopoiesis is blocked at its early stages. The hemocyte-
specific scavenger receptor Crq (Franc et al., 1996, 1999) colocal-
izes with the pan-glial maker Repo (Fig. 6F–F), indicating a
mixed glial and hemocyte phenotype. This goes along with the
expression/requirement of Gcm in both hemocytes and glia. Of
note, we never observed Repo expression in gcm(hemo)gcm
hemocytes at larval stages, suggesting that the Repo-expressing
cells do not survive or that Repo expression is not maintained.
Finally, because the gcmGal4 driver is expressed transiently and
early in the hemocyte lineages, we confirmed these data by using
additional hemocyte-specific drivers: srp(hemo), hemolectin and
hemese (Brückner et al., 2004; data not shown).
4
(Figure legend continued.) and D–D represent single sections of the insets indicated in
(B, C, and D), showing Repo, Srp, and Elav or HRP labeling (B, C, D), Repo only (B, C, D),
and Srp only (B, C, D). Scale bar, 100 m. E, F, Number of cells expressing Srp (E) and the




). n  8 embryos analyzed for each genotype. The means 	 SEM are represented on
the charts and the p values were calculated using ANOVA. G, Schematic representation of the
three Luciferase reporter vectors that were used in the cotransfection assays: the top one is
the control vector carrying the Firefly Luciferase coding sequence and the Firefly 3 UTR under
the UAS promoter. In the second construct (middle), the 3UTR has been replaced by the repo 3
UTR and in the last construct (bottom), the two miR-1 binding sites of the repo 3 UTR have been
mutated. H, Quantification of the Luciferase activity in extracts from S2 cells cotransfected with
pTub-miR-1, pTK-Renilla, and either pUAST-Luciferase-Luciferase-3UTR (Firefly 3 UTR; gray),
pUAST-Luciferase-Repo3UTR (repo 3 UTR; green), or pUAST-Luciferase-Repo-3UTRmiR-1
(repo 3 UTR miR-1, red). The values are normalized with the Renilla activity. The means 	
standard deviation are represented on the chart and the p values were calculated using student
test. **p  0.01.
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Repo represses the expression of
hemocyte markers in ectopic glial cells
Given the ability of Repo to inhibit the
hemocyte fate in the PM, we asked
whether it also represses that fate in glial
cells. In the simplest view, the lack of Repo
could transform glial cells into hemocytes,
as glia represent the resident macrophages
of the nervous system. We analyzed the
role of Repo first in ectopic glial cells and
then in endogenous glia.
Gcm expression throughout the neu-
rogenic region (scagcm) triggers ectopic
gliogenesis, whereas the same experiment
in repo-null embryos (repo LOF) triggers
ectopic Srp expression within the nervous
system. (Fig. 7A,B). To identify the cells
expressing Srp ectopically and to distin-
guish between hemocytes entering the
mutant nervous system (due to the lack of
Repo; Shklyar et al., 2014) versus pre-
sumptive glial cells expressing hemocyte
features in repo mutant embryos, we
needed a glial lineage marker that traces
cells in wild-type and in mutant animals.
We hence analyzed scagcm; repo LOF
embryos that also carry the repo-nGFP
transgene. Since Srp is a nuclear marker,
using the nuclear GFP tagging we could
show Srp/GFP colocalization as follows
(Fig. 7A–B): 3.5 	 0.8 cells/hemisegment
show Srp/GFP colocalization in scagcm;
repo LOF,repo-nGFP embryos compared
with 0 cells in scagcm;repo-nGFP em-
bryos (n  6 hemisegments in three em-
bryos; W test, p  2.10
4). This indicates
that presumptive glia express Srp, as op-
posed to the possibilities that repo-GFP-
positive cells phagocyte Srp-positive cells
(Lee and Jones, 2005; Laneve et al., 2013)
or that the lack of Repo induces Srp ex-
pression nonautonomously. Similar re-
sults were obtained upon using a second
early hemocyte marker, Ushaped (Ush;
Fig. 7C–D) as follows: 6.8 	 0.6 cells/
Figure 4. Repo can repress hemocyte differentiation ( gcm(hemo)Gal4 driver). A–B, E, H–H, C–D, F, I–I, Immunolabeling
on gcm(hemo)CD8GFP (Control; A–B, E, H–H) or gcm(hemo)CD8GFP,repo (repo GOF; C–D, F, I–I) embryos. Scale bar, 100
m. A, C, represent confocal projections of embryos labeled for GFP (green), Srp (red), and Repo (blue), dorsal view, stage 16; the
empty arrowheads indicate the Srp-positive GFP-negative cells of the fat body. A and C show the Srp signal alone. A, A, C, and
C show single sections of the insets indicated in A and C, the white arrowheads indicate the hemocytes (GFP/Srp double-positive
cells). Note that Repo is expressed in GFP-positive cells in repo GOF (C) and that the levels of Srp upon Repo overexpression (C) are
much lower compared with those observed in the control embryo (A). B, C4, and D are confocal projections, and B, C5, and
D are 3D reconstructions of the insets indicated in A and C. The numbers identify the hemocytes in each stack and their localization
4
in the 3D reconstruction after the y-axis rotation. Note that in
the control, the hemocytes appear as individual cells, whereas
in repo GOF the hemocytes aggregate. E and F represent con-
focal projections of embryos labeled for the late hemocyte
marker P1 (red), dorsal view, stage 14. G, G, Western blot
assay on protein extracts from S2 cells cotransfected with psr-
p(hemo)Gal4, pUAST-GFP, and increasing amounts of pPac5C-
repo (0 –3 g). pPac5C-lacZ was used as a transfection control
(G). The histogram in G represents GFP/-Gal relative quan-
tification. The amounts of transfected Repo were also verified.
n indicates the number of cotransfection assays. The means 	
SEM are represented on the chart and the p value was calcu-
lated using ANOVA. H, I, Single confocal sections of embryos
labeled for DAPI (blue), CD8GFP (green), and the apoptotic
marker DCP-1 (gray). H, H, I, I, Insets indicated in H and I;
the arrowheads indicate cells double positive for CD8GFP and
DCP-1. ***p  0.001.
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hemisegment show Ush/GFP colocalization in scagcm;repo
LOF,repo-nGFP embryos compared with 2.8 	 0.7 cells in
scagcm;repo-nGFP embryos (n  10 hemisegments in three
embryos; ANOVA, p  6.10
4). Within the neural tissue, we also
found Srp- or Ush-positive cells that are GFP negative (Fig.
7B–B,D,D, empty arrowheads). These cells likely repre-
sent hemocytes that have moved into a neural tissue that is no
longer properly formed/insulated (Shklyar et al., 2014).
Repo represses the expression of hemocyte markers in
endogenous glial cells
Next, we found that Repo is sufficient to repress the expression of
hemocyte genes in endogenous glia. We introduced the
srp(hemo)CD8GFP transgene in repo LOF, repo-nRFP animals
and found GFP expression (hemocyte tracer) in a fraction of
RFP-positive cells (glial tracer) that seemed localized dorsally in
the ventral cord of the repo LOF embryos, in correspondence of
the longitudinal connectives (Fig. 8A–C). This does not occur in
control animals and is in accord with the finding that Repo re-
presses the expression of the srp(hemo) promoter in S2 cells (Fig.
4G). Because the GFP of the srp(hemo)GFP line is localized at
the membrane and the RFP of the repo-nRFP line in the nucleus,
we could not formally exclude the possibility that hemocytes in-
vaded the mutant nervous system and engulfed the presumptive
glia. We hence used the anti-Srp antibody and analyzed the mu-
tant ventral cord upon subdividing it in two parts along the
z-axis, following the approach described by Shklyar et al. (2014).
The ventral part mainly contains cortex glial cells, and the dorsal
part mainly contains neuropil-associated glial cells (Ito et al.,
1995) in which astrocyte-like and ensheathing glia can be distin-
guished (Fig. 8D, simplified schematics; for review, see Freeman
and Rowitch, 2013; Limmer et al., 2014).
Using anti-Srp and anti-Fas2, which recognizes the three dor-
sally located longitudinal axonal fascicles of the ventral cord
(Santos et al., 2007; Fig. 8E–F,I–J 4), we found expression of the
hemocyte marker in presumptive neuropil-associated glial cells
(repo LOF, repo-nGFP; Fig. 8E–F). We found that 5.1% of the
presumptive glia (GFP-positive cells) express Srp (average of
0.96 	 0.14 cells/hemisegment are double-positive GFP/Srp of 20
neuropil glia; n  63 hemisegments in 11 embryos; W test, p 
0.00010). In similar assays using a second neuronal marker, anti-
HRP, we found nuclear colocalization between Ush labeling and
GFP (Fig. 8G,H) for 26% of the presumptive glia (4.9 	 0.5
cells/hemisegment are double-positive GFP/Ush; n  3 hemiseg-
ments in three embryos; W test, p  0.009). The orthogonal
sections of the VNC confirm that the hemocyte markers are ex-
pressed in the presumptive glia labeled with repo-nGFP in repo
LOF embryos (Fig. 8I–J 4).
In the neuropil-associated glia, astrocyte-like and ensheathing
glia can be distinguished according to Prospero (Pros) expres-
sion, which is present in astrocyte-like glia and is barely detect-
able in the ensheathing glia (Peco et al., 2016). The colabeling of
Srp and Pros indicates that both astrocyte-like glia (Fig. 8K–K 4,
empty arrowheads) and ensheathing glia (Fig. 8K–K 4, white ar-
rowheads) can express Srp in repo LOF embryos.
Since only dorsal cells display colabeling between the glial
tracer and the Srp/Ush transcription factors, we asked whether
distinct glial subtypes express different hemocyte markers in the
repo LOF embryos and analyzed the expression of the late hemo-
cyte marker Sn (Fig. 9A–D). The cells that express Sn are located
at the position of the cortex glia, mostly in the ventral part (Fig.
9A–D). Since Sn is involved in motility (Zanet et al., 2009), this
phenotype matches the observation that cortex glia are more mo-
tile in repo mutant embryos (Shklyar et al., 2014). As in the assays
performed on ectopic glia, we also found Sn-expressing cells that
correspond to hemocytes migrating into the defective nervous
system (Sn-positive/GFP-negative cells; Fig. 9E–F). The repo
LOF embryos display Sn labeling in 6% of the GFP-positive cells
(Shklyar et al., 2014). Thus, the lack of the Repo transcription
factor triggers the expression of subsets of hemocyte markers in a
fraction of presumptive glia. These data reveal for the first time a
hematopoietic potential for the embryonic glial cells of Drosophila.
Finally, we asked whether the lack of Repo converts glial cells
into mature and functional hemocytes by monitoring the expres-
sion of the hemocyte-specific phagocytosis receptor Crq (Franc
et al., 1999), but found no ectopic expression of that protein (Fig.
9G,H), in agreement with the hypothesis that the lack of Repo
does not simply reveal a default hemocyte fate.
In sum, Repo represses the expression of distinct hemocyte
markers in specific glial subtypes, hence revealing the complexity
of this cell population.
Table 1. Drivers used to target the neurogenic region, the mesoderm and the procephalic mesoderm
















The 1st column indicates the genotype, the second column indicates the region expressing the driver (embryo at stage 8, lateral view, anterior to the left) and in a cross section of the embryo (dorsal to the top) and the third column indicates
the region targeted.
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Repo acts as the guardian of the
glial fate
The fact that only a fraction of the pre-
sumptive glia expresses any hemocyte
marker in repo LOF embryos prompted us
to ask whether these cells display other de-
fects. Since Gcm represses the neuronal
fate and gain-of-function experiments
suggest that Repo contributes to the pro-
cess (Yuasa et al., 2003), we explored the
possibility that a fraction of the glial cells
lacking Repo express neuronal features.
Indeed, 22% of the presumptive glial cells
express the pan-neuronal marker Elav
(Yao and White, 1991; Berger et al., 2007)
in repo LOF; repo-nGFP embryos (Fig.
10A–D,F). These cells are scattered
throughout the ventral nerve cord (Fig.
10B,D) and do not coexpress the hemo-
cyte markers Srp (Fig. 10E–E) or Ush
(data not shown). Thus, the glial factor
Repo contributes to repressing the neuro-
nal as well as the hemocytic fates in differ-
ent glial subtypes. Moreover, removing
Elav as well as Repo allows more pre-
sumptive glia to express a hemocyte
marker, as elav;repo LOF double-mutant
embryos that also carry the repo-nGFP
transgene show twice as many cells ex-
pressing the Srp hemocyte marker in pre-
sumptive glia compared with those
observed in repo LOF embryos [Fig.
10F,G, 23% (third column) vs 11% (sec-
ond column)]. Thus, the neuronal factor
Elav is epistatic to Repo and contributes to
repression of the hemocyte fate, which
may explain why at early embryonic stages
Elav is expressed in a considerable num-
ber of cells expressing Repo (Berger et al.,
2007).
To further our understanding of the
role of the Repo transcription factor on
the glial fate, we also scored the total num-
ber of presumptive glia and assessed their
proliferative and cell death profile in repo
LOF embryos. The number of nuclei ex-
pressing the GFP in repo LOF; repo-nGFP
embryos is 30% lower compared with that
observed in wild-type animals (345.8 	
6.9 per embryo in WT compared with
196.0 	 35.8 in repo LOF; n  3 embryos;
ANOVA, p  0.0383). This is in agree-
ment with a slight reduction in cell divi-
sion and a slight increase in apoptosis;
anti-PH3 (Juan et al., 1998) was used to
Figure 5. Repo can repress hemocyte differentiation (srp(hemo)Gal4 driver). A–D, Immunolabeling on srp(hemo)RFP (Con-
trol; A–A5, C–C) or srp(hemo)RFP,repo (repo GOF; B–B5, D–D) embryos. Scale bar, 100 m. A, B, Confocal projections of
embryos labeled for RFP (red), Repo (blue), and the late hemocyte marker Sn (green). A and B show the Sn signal only, and
A–A5 and B–B5 show the inset indicated in A and B: from left to right, all channels together, Sn only, RFP only, and Repo only.
The empty arrowheads indicate hemocytes expressing RFP and no Sn in repo GOF. C, D, Confocal projections of embryos labeled for
RFP (red) and Repo (green). C and D) show the RFP signal only, and C and D represent single sections of the insets indicated in
4
C and D. E–H, Confocal projections of control and repo GOF
embryos (using the two different hemocyte-specific drivers)
labeled for Nazgul (red): gcm(hemo)CD8GFP (E, E),
gcm(hemo)CD8GFP,repo (F, F), srp(hemo)RFP (G), and
srp(hemo)RFP,repo (H). Lateral view, stage 14 (G, H)
show the Nazgul signal alone. Scale bar, 100 m.
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score for glial cell division: 4.9 	 1.0 dividing cells are present per
six hemisegments in WT embryos compared with 0.3 	 0.3 in
repo LOF embryos (n  3 embryos; W test, p  0.0361). Apopto-
sis was scored using the anti-CM1 antibody that recognizes the
activated Caspase-3 (Fig. 11A,B). No cells were observed in WT
embryos compared with 10.6 	 1.2 dying cells in repo LOF em-
bryos (n  3 embryos; six hemisegments were counted per em-
bryo; W test, p  0.0318). It is therefore likely that some cells
Figure 6. Gcm has a strong gliogenic potential in hemocyte precursors. A–D, Embryos gcm(hemo)CD8GFP (Control; A, A, C, C) and gcm(hemo)CD8GFP,medium gcm (Medium gcm GOF;
B, B, D, D). Scale bar, 100 m. A–B represent confocal projections of embryos labeled for GFP (green) and Repo (blue), lateral view, stage 14. B and B represent single confocal sections of the
inset indicated in B, the arrowheads indicate cells double positive for CD8GFP and Repo. C–D represent confocal projections of embryos labeled for GFP (green) and Nazgul (red), lateral view, stage
16. Brackets indicate territories exhibiting hemocytes. Note that the yellow color observed in C (oval) is an artifact created by the projection. D and D represent single confocal sections of the inset
indicated in D; arrowheads indicate ectopic glial labeling in hemocytes overexpressing Gcm. E–F, Single confocal sections of medium gcm GOF ( gcm(hemo)CD8GFP,medium gcm) embryos
labeled for Srp (red), Repo (blue); and GFP (E–E) and Crq (red), Repo (blue), and GFP (F–F). Hemocytes are indicated by asterisks, and those that also express Repo by white arrowheads. Note that
Repo ectopic expression does not affect Srp or Crq expression. Scale bar, 50 m. *p  0.05.
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missing the Repo protein no longer acquire/maintain the right
identity and eventually die. To make sure that the colocalization
between the presumptive glia (nuclear GFP) and the death maker
CM1 identifies dying cells (Fig. 11A–B,E), rather than glial cells
that are phagocytosing dead bodies, we compared the results ob-
tained on repo LOF; repo-nGFP embryos with those obtained on
repo; repo-CD8GFP embryos, in which the GFP is tagged to the
membrane (Fig. 11E).
As expected, in the latter case we did not observe colocaliza-
tion between the GFP and CM1 (Fig. 11C–C). Moreover, these
data further confirmed the lack of phagocytosis observed in repo
LOF embryos (Fig. 11D), likely due to defective Simu (Six Mi-
crons Under) and Drpr expression (Shklyar et al., 2014). Indeed,
whereas in wild-type embryos glial cell membranes completely
enwrap apoptotic bodies (Fig. 11C–C), in repo LOF embryos
these contacts are no longer established.
In sum, the only transcription factor that is expressed in all
glia and only in glia, Repo, acts as the true guardian of the glial
fate.
Discussion
During development, pioneer transcription factors trigger spe-
cific cell fates. More and more data, however, show that these
factors act in multiple lineages, raising the question of how each
lineage differentiates at the right place. Here we show that a pio-
neer factor acts in concert with tissue-specific cues to trigger
distinct fates in different territories and that this distinction is
maintained through reinforcing inhibitory pathways. The Dro-
sophila Gcm zinc finger protein promotes hematopoiesis in the
procephalic mesoderm, and gliogenesis in the nervous system.
The expression of its target and panglial transcription factor Repo
is repressed in the hematopoietic anlagen by mesodermal cues. In
turn, Repo represses the expression of hemocyte genes. These
sequential regulatory steps explain how Gcm induces two func-
tionally related but alternative cell fates in different territories
(Fig. 11F).
Tissue-specific cues inhibit the gliogenic potential of Gcm in
the hematopoietic anlagen
The Drosophila transcription factor Gcm is expressed and re-
quired for the differentiation of glia and blood, which share im-
mune features but also perform specific functions in the immune
and nervous systems. These cells originate from different layers,
glia from the ectoderm and hemocytes from the mesoderm, and
therefore display distinct molecular landscapes. We show here
that the mesoderm-specific transcription factor Twi and its target
miR-1 repress the expression of the panglial gene Repo in the
hemocyte anlagen. Other factors are certainly also involved in the
process as the mesodermal coexpression of Gcm and Srp, which is
necessary for hemocyte development, also represses Repo expres-
sion (data not shown). These tissue-specific cascades induce the
mesodermal molecular landscape, which in turn regulates Gcm
activity and biases its transcriptional output toward hemocyte
differentiation.
The coordinated activity of pioneer and tissue-specific factors
allows a limited number of transcription factors to produce the
high diversity of cell types present in complex organisms. For
example, the vertebrate GATA transcription factors regulate the
development of hematopoietic, neural, cardiac, or reproductive
tissues (Cantor and Orkin, 2005; Zaytouni et al., 2011; Chlon and
Crispino, 2012) and control specific target genes in the different
tissues due to the activity of tissue-specific transcription factors
that modify the transcriptional output of the GATA factors (Can-
tor and Orkin, 2005). It will be interesting to see whether in that
case as well post transcriptional regulation contributes to the
acquisition of cell specificity.
The Repo homeodomain-containing factor locks cells in the
glial fate
Gcm is expressed and necessary at early stages of glial devel-
opment, whereas the homeodomain containing Repo protein
is stably expressed in the glial cells. The lack of late glial mark-
ers observed in repo mutant embryos initially suggested a role
of Repo in glial terminal differentiation (Xiong et al., 1994;
Yuasa et al., 2003). However, the ectopic expression of non-
glial markers in those embryos shows that Repo also controls
cell plasticity. This indicates that homeodomain containing
transcription factors can provide the molecular relay from
multipotency to a fully differentiated state once the transient
expression of pioneer factors extinguishes. It is possible that
neural-specific factors also help sustain Repo expression in the
nervous system, hence providing a favorable landscape for
glial differentiation.
Figure 7. Repo represses the Gcm hematopoietic potential in the neuroectoderm. A–D, Confocal projections of embryos scaweak gcm;repo-nGFP (Weak gcm GOF; A, C) and scaweak
gcm/repo-nGFP;repo 
 / 
 (Weak gcm GOF, repo LOF; B, D) labeled for GFP (green) and Srp (red; A–B) or GFP (green) and Ush (red; C–D), ventral view, stage 16. The dashed lines define the VNC
(A–D). B–B, and D–D) represent single sections of the insets indicated in B and D; they show nGFP labeling only, Srp or Ush labeling only, and colabeling Srp or Ush with nGFP, respectively.
White arrowheads indicate nGFP/Srp (B–B) or nGFP/Ush (D–D) double-positive cells, empty arrowheads indicate Srp- or Ush-positive and nGFP-negative cells in gcm GOF repo LOF embryos.
These are hemocytes recruited to the VNC that are not properly insulated due to the mutant background (Shklyar et al., 2014). Scale bar, 50 m.
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Figure 8. Repo is required to repress hemocyte transcription factors in developing glia. A, B, Confocal projections of embryos srp(hemo)CD8GFP/repo-nRFP (Control; A) and
srp(hemo)CD8GFP/repo-nRFP;repo 
 / 
 (repo LOF; B) labeled for GFP (green) and RFP (red), ventral view. B–B, C–C, Single sections of the inset indicated in B. Note that the single sections
were acquired at different focal planes in the VNC. The arrows indicate GFP/RFP double-positive cells. Scale bar, 100 m. D, Simplified schematic of a transversal section of the VNC from a mature
embryo. Glial cell subtypes are defined according to their localization: surface (pale blue), cortex (red), and neuropil-associated glia (green; Ito et al., 1995; (Figure legend continues.)
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The robustness of the glial fates relies on the activity of cell-
specific genes such as Repo and Elav, which repress the expres-
sion of Srp in the nervous system. Our data also suggest that glial
(Repo) and neuronal (Elav) factors both repress ectopic hemato-
poiesis in the neural territory while counteracting each other to
maintain the glial and the neuronal fates, respectively. This mo-
lecular network explains why cells adopt the neuronal default fate
in the absence of Gcm, whereas they start expressing hemocyte
markers in the absence of Repo, and even more so in the absence
of both Repo and Elav.
Thus, cell-specific pathways and feedback loops allow a single
pioneer factor to affect different cell fates. Such molecular check-
points acting in parallel and in sequence allow the maintenance of
a stable fate.
Lack of Repo triggers different phenotypes in distinct
glial subtypes
The glial cells of the embryonic ventral nerve cord are subdivided
into three main subtypes (surface-associated, cortex-associated,
and neuropil-associated) based on their morphology, position,
and function (Ito et al., 1995; Beckervordersandforth et al., 2008).
The large and flattened glial cells associated with the surface form
the BBB (Auld et al., 1995). Glial cells located in the cortex are star
shaped and intermingled with neuronal bodies, their cytoplasmic
projections contacting multiple synapses (Freeman and Doherty,
2006; Freeman, 2015). Cortex glia help to clear the debris induced
by neuronal programmed cell death (Freeman et al., 2003; Shk-
lyar et al., 2013, 2014; Kurant et al., 2008). Finally, glial cells
associated with the axons enwrap them in a multilayer sheath
promoting the conduction of nerve impulses, and a subset of
them has also been called astrocyte-like glia (Hidalgo and Booth,
4
(Figure legend continued.) Beckervordersandforth et al., 2008). The neuropil-associated glia
can be further defined as astrocyte-like and ensheathing glia. E–L4, Immunolabeling of the
dorsal part of the VNC of embryos repo-nGFP (Control) and repo 
 / 
;repo-nGFP (repo LOF).
E–H, Confocal projection of stage 15 embryos labeled for GFP (green), Fas2 (gray), and Srp (red;
E, F); and GFP (green), HRP (gray), and Ush (red; G, H). Scale bar, 50 m. The white arrowheads
indicate cells coexpressing repo-nGFP and Srp (E, F) or repo-nGFP and Ush (G, H). Scale bar, 50
m. I–J4, Confocal projections of segments from stage 15 embryos labeled for GFP (green),
Fas2 (gray), and Srp (red), acquired with thin section (0.2 m) to build an orthogonal section.
I and J show the stack with the three labels, I and J show the stack with GFP and Srp, and
I and J show the stack with Srp only. I, I4, J, and J4 show the orthogonal section along
the z- and y-axes of the dashed line in I and J [dv, from dorsal (left) to ventral (right)]. The
white arrowheads indicate glia expressing Srp in repo GOF. Scale bar, 10 m. K, L, Confocal
projection of stage 15 embryos labeled for GFP (green), Pros (gray), and Srp (red). K–K4 and
L–L4 show the insets indicated in K and L with all channels together: GFP only, Pros only, and
Srp only, respectively. White arrowheads indicate ensheathing glia (Pros
), and empty arrow-
heads indicate the astrocyte-like glia (Pros ). Scale bar, 100 m.
Figure 9. Repo is required to repress the hemocyte marker Sn in developing glia. A–H, Immunolabeling of the VNC of embryos repo-nGFP (Control) and repo 
 / 
;repo-nGFP (repo LOF). Scale bar,
50 m. A–D, Stage 14 embryos labeled for GFP (green) and Sn (red). D and D show single sections of the inset indicated in D. A and C show the dorsal part of the VNC, and B and D show the ventral
part. E, F, Confocal projections of the whole VNC labeled for GFP (green), Sn (red), and Elav (gray); the dashed line indicates the position of the orthogonal section along the z- and y-axes of the VNC
presented in E and F. Note the presence of Sn-positive/GFP-negative cells within the VNC in repo LOF embryo; these are hemocytes recruited to the VNC following the loss of repo (Shklyar et al.,
2014). G, H, Embryos labeled for GFP (green) and Crq (red).
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2000; Sepp et al., 2000; Sepp and Auld, 2003; Freeman and Do-
herty, 2006; Freeman, 2015). These glia are known to act as scav-
engers in response to developmental signals and to trauma, likely
due to their proximity to signaling axons. Typically, in the adult
brain they phagocytose degenerating axons after brain injury
(Doherty et al., 2009) and, after puparium formation, axon-
associated glia of the mushroom body control ecdysone-
dependent axons pruning (Awasaki and Ito, 2004; Kato et al.,
2011; Kato and Hidalgo, 2013; Hakim et al., 2014; Boulanger and
Dura, 2015).
Repo is expressed in the three cell types, and its lack affects
them all (Giesen et al., 1997; Yuasa et al., 2003; Kerr et al., 2014);
however, the repo mutant phenotypes reveal the underlying di-
versity of the glial subtypes as, in the absence of Repo, neuropil-
associated glia express early hemocyte transcription factors but
not Sn, whereas cortex glia express Sn, but not the Srp or Ush
transcription factors. Of note, Sn is necessary for cell motility
(Adams, 2004; Zanet et al., 2009) and Shklyar et al. (2014) ob-
served that repo mutant cortex glia are very motile. In the future,
it will be interesting to determine the transcriptional land-
scape of the different glial subtypes as, for example, cortex glia
may be specialized in removing dead cell bodies, whereas
neuropil-associated glia may specifically target and remove
axons and dendrites.
Although glial cells act as macrophages, they do not have a
default hemocyte phenotype, rather, they constitute a very
specialized population of scavenger cells. Similarly, vertebrate
microglia, cells of immune origin that provide the first re-
sponse to nervous system challenge, display a molecular sig-
nature that is distinct from that of macrophages (Prinz and
Priller, 2014). In agreement with the related but distinct func-
tion of Drosophila glia and hemocytes, their development also
presents common and distinct features. The Crq scavenger
receptors (Franc et al., 1999) are a potential target of Gcm
(Cattenoz et al., 2016) and are expressed only in hemocytes
(Shklyar et al., 2014). Another potential Gcm target, Simu
(also called Nimrod C4), is a phagocytic receptor necessary in
both glia and hemocytes (Kurucz et al., 2007b; Kurant et al.,
2008), but Gcm is known to regulate Simu expression in glia,
not in hemocytes (Shklyar et al., 2014; Shlyakhover et al.,
2018). Finally, the phagocytic receptor Drpr is necessary for
phagocytosis by both glia and hemocytes but is not regulated
directly by Gcm (Freeman et al., 2003; Shklyar et al., 2014;
Shlyakhover et al., 2018). Future experiments will address the
point of similarities versus differences existing between glia
and hemocytes as well as their specific requirements for the
Gcm pathway.
Figure 10. Repo represses both hemocyte and neuronal differentiation. A–D, Embryos of the following genotypes: repo-nGFP (Control) and repo 
 / 
;repo-nGFP (repo LOF), ventral view, stage
15. The ventral and the dorsal parts of the VNC were analyzed separately. Labeling: GFP (green) and Elav (gray). Scale bar, 50 m. B–B and D–D show single sections of the insets indicated
in B and D. Arrowheads indicate ectopic GFP/Elav double-positive cells. E–E, Dorsal part of a repo 
 / 
;repo-nGFP (repo LOF) embryo labeled for Srp (red), Elav (gray), and GFP (green); the channels
are presented individually in E, E, and E, respectively. White arrowheads indicate GFP/Elav double-positive cells, and empty arrowheads indicate GFP/Srp double-positive cells. Scale bar, 50 m.
F, G, Graphs showing the number and the percentage of GFP/Elav double-positive cells (F) or GFP/Srp double-positive cells (G) per hemisegment in Control, repo LOF, repo LOF elav LOF
double-mutant, and elav LOF embryos. n indicates the number of hemisegments counted in three embryos. The means 	 SEM are represented on the chart and the p values were calculated using
Krustal-Wallis test. *p  0.05, **p  0.01, ***p  0.001.
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Of flies and vertebrates
Drosophila and vertebrate glial cells share numerous functions in
controlling neuron homeostasis, recycling neurotransmitters,
and insulating axons (Freeman and Doherty, 2006); however, the
transcriptional program triggering the first steps of gliogenesis
are not evolutionarily conserved. In Drosophila, the Gcm tran-
scription factor constitutes the major regulatory gene and acts as
a molecular switch between neuron and glial cells. Although the
vertebrate Gcm orthologs seem to maintain some gliogenic po-
tential in vitro (Kim et al., 1998; Reifegerste et al., 1999; Buzanska
et al., 2001; Iwasaki et al., 2003; Soustelle et al., 2007), they are
neither expressed nor required in glia. Moreover, no true glial
determinant has been so far identified in vertebrates (Hitoshi et
al., 2011). Even more strikingly, the vertebrate genomes do not
contain the coding sequences for the panglial factor Repo (no
orthologs found so far), a molecular signature that seems shared
throughout the arthropod clade (Wakamatsu, 2004; Boyan et al.,
2011; Mysore et al., 2011; Nasu and Hara, 2012).
Our findings raise the question of the evolutionary link be-
tween vertebrate and Drosophila gliogenesis. While the hypothe-
sis of an independent origin of vertebrate and invertebrate glia
remains to be tested (Hartline, 2011), sequencing the genome
and analyzing the single-cell transcriptome of simple organisms
will establish when Gcm and Repo appear in evolution and where
they are expressed/required within/outside the nervous system.
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254 • J. Neurosci., January 9, 2019 • 39(2):238 –255 Trébuchet, Cattenoz et al. • Repo Suppresses Hematopoiesis
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